Overview: Stool Examination Routine Panel
Introduction: The Stool Examination Routine Panel is a diagnostic tool designed for routine stool analysis using stool samples. In India, GI infections (parasitic, bacterial) affect millions annually, with helminths (Ascaris, hookworm) prevalent in rural/low-SES (~20-50 percent in children), causing anemia, malnutrition, and growth stunting. High morbidity from under-testing leading to delayed antiparasitic therapy, limited microbiology labs, causing chronic diarrhea or nutritional deficits. Per microbiology practices aligned with ICMR and National Centre for Disease Control guidelines, the test employs microscopy for color, consistency, mucus, blood, ova, cysts, parasites, RBC, WBC, fat globules, pH, reducing substances, occult blood, and bacteria over 1-2 days with high accuracy, valuable for detecting common intestinal pathogens. This diagnostic falls under infection screening and targets patients with diarrhea, abdominal pain, or malnutrition, addressing accurate detection to guide deworming or antibiotics. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling affordable stool evaluation and reducing parasitic burden. Its stool-based approach ensures reliable morphological analysis.
Other Names: Stool Routine Pnl.
FDA Status: FDA approved, CLIA certified for microbiology/clinical pathology, compliant with 2025 standards.
Historical Milestone: Routine stool microscopy standard in parasitology; in India, key in diarrheal surveillance.
Purpose: The test assesses 14 parameters including color and ova to guide GI infection screening, detect parasites/blood, inform deworming.
Test Parameters: 1. Color, 2. Consistency, 3. Mucus, 4. Blood, 5. Ova, 6. Cysts, 7. Parasites, 8. RBC, 9. WBC, 10. Fat Globules, 11. pH, 12. Reducing Substances, 13. Occult Blood, 14. Bacteria.
Pretest Condition: No fasting required; patients should have GI symptoms.
Specimen: 5 g stool in 1 sterile container, transported within specified times to maintain viability.
Sample Stability at Room Temperature: 24 hours with proper handling to preserve parasite morphology, ensuring reliable test performance.
Sample Stability at Refrigeration: 48 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: Not applicable (fresh sample preferred for microscopy).
Medical History: Patients should provide details on diarrhea, travel, diet.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of undetected parasites including malnutrition, benefits of screening, and minimal discomfort from stool collection.
Procedural Considerations: The test involves sample processing using microscopy by trained personnel to ensure sterile technique and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, or low parasite load can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: Ova/cysts/parasites indicate infection; occult blood suggests bleeding, necessitating specialist input.
Specialist Consultation: Gastroenterologists or infectious disease specialists should be consulted for management.
Additional Supporting Tests: Stool antigen/PCR, endoscopy for confirmation.
Test Limitations: Sensitivity variable; comprehensive approach required.
References: Indian Journal of Medical Microbiology 2024, Parasitology Studies India 2023.
